Cassava Sciences is a clinical-stage biotechnology company based in Austin, Texas. Cassava Sciences mission is to detect and treat neurodegenerative diseases, such as Alzheimer’s disease. Cassava's novel science is based on stabilizing—but not removing—a critical protein in the brain. Cassava's product candidates have not been approved by any regulatory authority, and their safety, efficacy or other desirable attributes have not been established.